Bruno M. Schmied
Papers
2
Total Citations
18
H-Index
2
About
Bruno M. Schmied is a leading surgical oncologist whose research focuses on refining minimally invasive techniques for colorectal and hepatobiliary cancers, with a particular emphasis on improving patient survival and procedural precision. His major contributions include critical evaluations of transanal total mesorectal excision (taTME) for rectal cancer, where his 2024 propensity score-adjusted cohort study—garnering 11 citations—provided sobering evidence that taTME may be associated with worse survival compared to traditional approaches, challenging prevailing clinical assumptions. In the domain of liver interventions, Schmied’s pioneering 2009 work on needle-based navigation systems (7 citations) compared human versus robot operator error, establishing foundational benchmarks for accuracy in CT-guided percutaneous procedures. This dual focus on oncologic outcomes and technological optimization underscores his commitment to evidence-based surgical innovation. His impact is reflected in citations that shape clinical guidelines and robotic system design, while his willingness to question established techniques—even those he helped advance—demonstrates intellectual integrity. For students and researchers, Schmied’s work offers a masterclass in balancing technical ambition with rigorous outcomes assessment, reminding the field that surgical progress demands both innovation and honest scrutiny.
Research Focus
Key Achievements
Top Papers
- 1
- 2